alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomeOffice of the SpokespersonPress Releases...Designation of Two DPRK Individuals Supporting the DPRK’s Unlawful Weapons of Mass Destruction and Missile Programs

# 									Designation of Two DPRK Individuals Supporting the DPRK’s Unlawful Weapons of Mass Destruction and Missile Programs							

Press Statement

Antony J. Blinken, Secretary of State

June 15, 2023

Today, the United States is designating two Beijing-based Democratic People’s Republic of Korea (DPRK) nationals connected to the DPRK’s weapons of mass destruction (WMD) procurement. The DPRK’s development of its missile programs directly threatens regional and international security, and the United States will continue to take action to curtail activities in support of those programs.

The United States is designating Choe Chol Min and his wife Choe Un Jung. Choe Chol Min has worked with DPRK weapons trading officials, People’s Republic of China (PRC) nationals, and other associates to procure materials used in the production of DPRK missiles. He has also supported Second Academy of Natural Sciences (SANS) representatives to facilitate the importation of over a thousand DPRK workers into the PRC to unlawfully generate income abroad for the DPRK regime. Choe Un Jung, who is officially assigned to the DPRK Embassy in the PRC, helped coordinate an order with one or more SANS associates for dual-use bearings used in DPRK missile production.

*Choe Chol Min is being designated for acting or purporting to act for or on behalf of, directly or indirectly, the SANS, pursuant to Executive Order 13382. Choe Un Jung is being designated for being a North Korean person who has engaged in commercial activity that generates revenue for the Government of North Korea or the Workers’ Party of Korea, pursuant to Executive Order 13810. For more information about this designation, please see the Department of the Treasury’s press release.*

Tags

Bureau of East Asian and Pacific AffairsChinaInternational SecurityNorth KoreaOffice of the SpokespersonThe Secretary of StateWeapons of Mass Destruction

## Related Articles

-  											 									
Read more
 

Back to Top
Editorial Note on Part 422
Editorial Note: Nomenclature changes to part 422 appear at 70 FR 4741, Jan. 28, 2005.

§ 422.2480 MLR review and non-compliance. To ensure the accuracy of MLR reporting, CMS conducts selected review of data submitted under § 422.2460 to determine that that the MLRs and remittance amounts under § 422.2410(b) and sanctions under § 422.2410(c) and (d), were accurately calculated, reported, and applied. ( a ) The reviews include a validation of amounts included in both the numerator and denominator of the MLR calculation reported to CMS.
( b ) MA organizations are required to maintain evidence of the amounts reported to CMS and to validate all data necessary to calculate MLRs.
( c ) ( 1 ) Documents and records must be maintained for 10 years from the date such calculations were reported to CMS with respect to a given MLR reporting year.
( 2 ) MA organizations must require any third party vendor supplying drug or medical cost contracting and claim adjudication services to the MA organization to provide all underlying data associated with MLR reporting to that MA organization in a timely manner, when requested by the MA organization, regardless of current contractual limitations, in order to validate the accuracy of MLR reporting.
( d ) Data submitted under § 422.2460, calculations, or any other MLR submission required by this subpart found to be materially incorrect or fraudulent— ( 1 ) Is noted by CMS;
( 2 ) Appropriate remittance amounts are recouped by CMS; and
( 3 ) Sanctions may be imposed by CMS as provided in § 422.752.
[78 FR 31307, May 23, 2013, as amended at 83 FR 16736, Apr. 16, 2018]
1

In The

Court of Appeals

Ninth District of Texas at Beaumont

__________________

NO. 09-23-00400-CR

__________________

STEVEN CRAIG ESKRIDGE, Appellant

V.

THE STATE OF TEXAS, Appellee

__________________________________________________________________

On Appeal from the 221st District Court

Montgomery County, Texas

Trial Cause No. 23-03-04553-CR

__________________________________________________________________

MEMORANDUM OPINION

On July 13, 2023, the trial court sentenced Steven Craig Eskridge on an 

indictment for theft. On December 18, 2023, Eskridge filed a notice of appeal pro 

se. 

The District Clerk then sent Eskridge’s notice of appeal and the trial court’s 

certification to the Ninth Court of Appeals. The trial court’s certification shows that 

this is a plea-bargain case and that Eskridge has no right to appeal.
2

On December 20, 2023, we notified the parties that we would dismiss the 

appeal unless the appellant established the trial court’s certification was incorrect.

Even though Eskridge responded to the Court’s notice, his response fails to establish 

that the trial court’s certification that states he has no right to appeal is incorrect.

Because the record lacks a certification that shows Eskridge has the right of appeal, 

we dismiss the appeal.1 See Tex. R. App. P. 25.2(d), 43.2(f).

APPEAL DISMISSED.

PER CURIAM

Submitted on February 6, 2024

Opinion Delivered February 7, 2024

Do Not Publish

Before Golemon, C.J., Horton and Johnson, JJ.

1 We note that it appears Eskridge filed a notice of appeal too late to perfect 

an appeal. See Tex. R. App. P. 26.2, 26.3.
[670 NYS2d 1013]

#### In the Matter of Anthony Anzalone, Petitioner, v Pat Bonanno, as Assistant District Attorney of Bronx County, et al., Respondents.

Supreme Court, Bronx County,

February 3, 1998

APPEARANCES OF COUNSEL

*Anthony Anzalone,*petitioner *pro se. Robert T. Johnson, District Attorney of*Bronx County *(Leslie Catherine Perrin of*counsel), for plaintiff.

OPINION OF THE COURT

Joseph N. Giamboi, J.

In this proceeding brought pursuant to CPLR 7803 (1), petitioner Anthony Anzalone seeks an order directing the respondents to turn over to petitioner records related to his arrest and indictment in December of 1987 and that his entire criminal file be turned over for an in camera inspection of the *160above records and related documents, pursuant to the Freedom of Information Law (hereinafter FOIL) (Public Officers Law art 6).

The petitioner, a prison inmate, seeks documents in connection with his arrest and conviction for criminal possession of a controlled substance in the first degree and criminal sale of a controlled substance in the first degree. On December 1, 1988 petitioner was found guilty of the charges and on June 13, 1989 petitioner was sentenced to 20 years to life.

Section 89 (3) of the Public Officers Law, FOIL, provides, in relevant part: “Each entity subject to the provisions of this article * * * shall make such record available to the person requesting it * * * the entity shall provide a copy of such record and certify to the correctness of such copy * * * or as the case may be, shall certify that it does not have possession of such record or that such record cannot be found after diligent search”.

Respondents have submitted the affidavit of Assistant District Attorney Leslie Catherine Perrin certifying that, after diligently searching for the files, they cannot be located, and thus were not in respondents’ possession.

In reviewing the submitted papers the court finds that the respondents provided a sufficiently detailed basis to support and demonstrate that the respondents’ office did conduct a diligent search for the records and were unable to locate them. *(Matter of Smith v Capasso,*200 AD2d 502 [1st Dept]; *Matter of Calvin K. of Oakknoll v De Francesco,*200 AD2d 619 [2d Dept].)

Further, the respondents provided a sufficiently detailed basis to support their claims of nonpossession and exemption to negate the necessity of an in camera review of the documents. *(Matter of Smith v Capasso, supra; Matter of Fink, v Lefkowitz,*47 NY2d 567.) The petitioner has failed to offer a factual basis for his claim to the contrary *(see, Matter of Ahlers v Dillon,*143 AD2d 225) but, instead, offered only speculation regarding the respondents’ failure to locate a file from 10 years ago. *(See, Matter of Corbin v Ward,*160 AD2d 596; *Matter of Calvin K. of Oakknoll v De Francesco,*200 AD2d 619, *supra.)*

Accordingly, petitioner’s CPLR article 78 application is denied in its entirety, and the proceeding dismissed.
§ 423.1984 Effect of a revised determination or decision. ( a ) *Coverage determinations.* The revision of a coverage determination is binding unless an enrollee submits a request for a redetermination that is accepted and processed in accordance with § 423.580 through § 423.590.
( b ) *Redeterminations.* The revision of a redetermination is binding unless an enrollee submits a request for an IRE reconsideration that is accepted and processed in accordance with § 423.600 through § 423.604.
( c ) *Reconsiderations.* The revision of a reconsideration is binding unless an enrollee submits a request for an ALJ hearing that is accepted and processed in accordance with §§ 423.2000 through 423.2063.
( d ) *ALJ or attorney adjudicator decisions.* The revision of an ALJ or attorney adjudicator decision is binding unless an enrollee submits a request for a Council review that is accepted and processed as specified in §§ 423.2100 through 423.2130.
( e ) *Council review.* The revision of a Council determination or decision is binding unless an enrollee files a civil action in which a Federal District Court accepts jurisdiction and issues a decision.
( f ) *Appeal of only the portion of the determination or decision revised by the reopening.* Only the portion of the coverage determination, redetermination, reconsideration, or hearing decision revised by the reopening may be subsequently appealed.
( g ) *Effect of a revised determination or decision.* Consistent with § 423.1978(c), a revised determination or decision is binding unless it is appealed or otherwise reopened.
[74 FR 65363, Dec. 9, 2009, as amended at 82 FR 5127, Jan. 17, 2017; 84 FR 19872, May 7, 2019]
# C_2006111EN.01000201.xml

| 11.5.2006 | EN | Official Journal of the European Union | C 111/2 |
| --- | --- | --- | --- |

11.5.2006

EN

Official Journal of the European Union

C 111/2

---

Euro exchange rates (1)

1

9 May 2006

(2006/C 111/02)

1 euro=

1 euro

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2697 |
| JPY | Japanese yen | 141,62 |
| DKK | Danish krone | 7,4574 |
| GBP | Pound sterling | 0,6835 |
| SEK | Swedish krona | 9,321 |
| CHF | Swiss franc | 1,5582 |
| ISK | Iceland króna | 89,12 |
| NOK | Norwegian krone | 7,7995 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5751 |
| CZK | Czech koruna | 28,29 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 260,85 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,696 |
| MTL | Maltese lira | 0,4293 |
| PLN | Polish zloty | 3,8427 |
| RON | Romanian leu | 3,4662 |
| SIT | Slovenian tolar | 239,63 |
| SKK | Slovak koruna | 37,42 |
| TRY | Turkish lira | 1,7065 |
| AUD | Australian dollar | 1,6515 |
| CAD | Canadian dollar | 1,4114 |
| HKD | Hong Kong dollar | 9,8431 |
| NZD | New Zealand dollar | 2,0292 |
| SGD | Singapore dollar | 1,9925 |
| KRW | South Korean won | 1 183,36 |
| ZAR | South African rand | 7,7222 |
| CNY | Chinese yuan renminbi | 10,1659 |
| HRK | Croatian kuna | 7,2795 |
| IDR | Indonesian rupiah | 11 097,18 |
| MYR | Malaysian ringgit | 4,5582 |
| PHP | Philippine peso | 65,263 |
| RUB | Russian rouble | 34,38 |
| THB | Thai baht | 47,787 |

Currency

Exchange rate

USD

US dollar

1,2697

JPY

Japanese yen

141,62

DKK

Danish krone

7,4574

GBP

Pound sterling

0,6835

SEK

Swedish krona

9,321

CHF

Swiss franc

1,5582

ISK

Iceland króna

89,12

NOK

Norwegian krone

7,7995

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5751

CZK

Czech koruna

28,29

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

260,85

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,696

MTL

Maltese lira

0,4293

PLN

Polish zloty

3,8427

RON

Romanian leu

3,4662

SIT

Slovenian tolar

239,63

SKK

Slovak koruna

37,42

TRY

Turkish lira

1,7065

AUD

Australian dollar

1,6515

CAD

Canadian dollar

1,4114

HKD

Hong Kong dollar

9,8431

NZD

New Zealand dollar

2,0292

SGD

Singapore dollar

1,9925

KRW

South Korean won

1 183,36

ZAR

South African rand

7,7222

CNY

Chinese yuan renminbi

10,1659

HRK

Croatian kuna

7,2795

IDR

Indonesian rupiah

11 097,18

MYR

Malaysian ringgit

4,5582

PHP

Philippine peso

65,263

RUB

Russian rouble

34,38

THB

Thai baht

47,787

---

(1)

1

Source: reference exchange rate published by the ECB.

Source:

---
----

Non-opposition to a notified concentration

(Case COMP/M.4019 — Fraport/Deutsche Bank/Budapest Airport)

(2006/C 14/03)

(Text with EEA relevance)

On 21 December 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

----
EXHIBIT 21.1


<TABLE>
<CAPTION>

                                                           State or Jurisdiction          Trade Name
Name of Subsidiary                                           of Incorporation              (if any)
-----------------------------------------------------------------------------------------------------------

<S>                                                           <C>                              <C>
Omega Bank, N.A.                                              United States                    -
P.O. Box 298
State College, PA 16804

Hollidaysburg Trust Company                                   Pennsylvania                     -
224 Allegheny Street
Hollidaysburg, PA 16648

Penn Central National Bank                                    United States                    -
431 Penn Street
Huntingdon, PA 16652

Central Pennsylvania Investment Company                       Delaware                         -
1105 N. Market Street
Wilmington, DE 19899

Central Pennsylvania Life Insurance Company                   Arizona                          -
1421 E. Thomas Road
Phoenix, AZ 85014

Central Pennsylvania Leasing, Inc.                            Pennsylvania                     -

Central Pennsylvania Real Estate, Inc.                        Pennsylvania                     -


</TABLE>
HomeOffice of the SpokespersonPress Releases...IDF Releases Shireen Abu Akleh Report 

# 									IDF Releases Shireen Abu Akleh Report 							

Press Statement

Ned Price, Department Spokesperson

September 5, 2022

Today, the Israel Defense Forces (IDF) reported that it had concluded its investigation into the circumstances surrounding Palestinian-American journalist Shireen Abu Akleh’s death, and stated there is a high possibility that Ms. Abu Akleh was accidentally hit by IDF gunfire. We welcome Israel’s review of this tragic incident, and again underscore the importance of accountability in this case, such as policies and procedures to prevent similar incidents from occurring in the future.

The United States has made it a priority to mitigate and respond to civilian harm caused by military operations.  The Department of Defense recently underscored the need to improve its own assessments and practices to ensure civilian harm mitigation and we will continue to share best practices with our military partners and allies around the world.

Our thoughts remain with the Abu Akleh family as they grieve this tremendous loss – and with the many others worldwide who brought Shireen and her news reports into their homes for more than two decades.  Not only was Shireen an American citizen, she was a fearless reporter whose journalism and pursuit of truth earned her the respect of audiences around the world.

Tags

Accountability ReportBureau of Near Eastern AffairsIsraelOffice of the Spokesperson

## Related Articles

-  											 									
Read more
 

Back to Top
EXHIBIT 11

                            U.S.B. HOLDING CO., INC.

                    COMPUTATION OF EARNINGS PER COMMON SHARE

          FOR THE THREE YEARS ENDED DECEMBER 31, 2001, 2000, AND 1999

<TABLE>
<CAPTION>
----------------------------------------------------------------------------------------------------------------
                                                                          (000's, except share amount)
                                                                   2001                 2000            1999
----------------------------------------------------------------------------------------------------------------
<S>                                                              <C>                  <C>             <C>
NUMERATOR:

   Net Income                                                       $20,761              $19,612         $16,685

   Less preferred stock dividends                                        11                   11              11
----------------------------------------------------------------------------------------------------------------
   Numerator for basic and diluted earnings
      per common share - net income available to
      common stockholders                                           $20,750              $19,601         $16,674
================================================================================================================
DENOMINATOR:

   Denominator for basic earnings per
      common share - weighted average shares                     18,308,347           18,195,110      18,341,089

   Effects of dilutive securities:

      Director and employee stock options                           435,206              561,663         745,809
      Restricted stock not vested                                     2,064                2,164           3,191
----------------------------------------------------------------------------------------------------------------
Denominator for diluted earnings per common
    share - adjusted weighted average shares                     18,745,617           18,758,937      19,090,089
================================================================================================================
Basic earnings per common share                                      $ 1.13               $ 1.08          $ 0.91

Diluted earnings per common share                                    $ 1.11               $ 1.04          $ 0.87
================================================================================================================
</TABLE>
### Distribution of elements in sedimentary rocks of the Colorado Plateau - a preliminary report

By: William Louis Newman

                            https://doi.org/10.3133/b1107F

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Tables:                               - **Table 20**                            (pdf)
  - **Table 21**                            (pdf)
  - **Table 22**                            (pdf)
  - **Table 23**                            (pdf)
  - **Table 24**                            (pdf)
  - **Table 25**                            (pdf)
  - **Table 26**                            (pdf)
  - **Table 27**                            (pdf)
  - **Table 28**                            (pdf)
  - **Table 29**                            (pdf)
  - **Table 30**                            (pdf)
  - **Table 31**                            (pdf)
  - **Table 32**                            (pdf)
  - **Table 33**                            (pdf)
  - **Table 34**                            (pdf)
  - **Table 35**                            (pdf) 
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

No abstract available.

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
Editorial Note on Part 422
Editorial Note: Nomenclature changes to part 422 appear at 70 FR 4741, Jan. 28, 2005.

§ 422.156 Compliance deemed on the basis of accreditation. ( a ) *General rule.* An MA organization is deemed to meet all of the requirements of any of the areas described in paragraph (b) of this section if— ( 1 ) The MA organization is fully accredited (and periodically reaccredited) for the standards related to the applicable area under paragraph (b) of this section by a private, national accreditation organization approved by CMS; and
( 2 ) The accreditation organization used the standards approved by CMS for the purposes of assessing the MA organization's compliance with Medicare requirements.
( b ) *Deemable requirements.* The requirements relating to the following areas are deemable: ( 1 ) *Quality improvement.* The deeming process should focus on evaluating and assessing the overall quality improvement (QI) program. However, the chronic care improvement programs (CCIPs) will be excluded from the deeming process.
( 2 ) Antidiscrimination.
( 3 ) Access to services.
( 4 ) Confidentiality and accuracy of enrollee records.
( 5 ) Information on advance directives.
( 6 ) Provider participation rules.
( 7 ) The requirements listed in § 423.165 (b)(1) through (3) of this chapter for MA organizations that offer prescription drug benefit programs.
( c ) *Effective date of deemed status.* The date on which the organization is deemed to meet the applicable requirements is the later of the following: ( 1 ) The date on which the accreditation organization is approved by CMS.
( 2 ) The date the MA organization is accredited by the accreditation organization.
( d ) *Obligations of deemed MA organizations.* An MA organization deemed to meet Medicare requirements must— ( 1 ) Submit to surveys by CMS to validate its accreditation organization's accreditation process; and
( 2 ) Authorize its accreditation organization to release to CMS a copy of its most recent accreditation survey, together with any survey-related information that CMS may require (including corrective action plans and summaries of unmet CMS requirements).
( e ) *Removal of deemed status.* CMS removes part or all of an MA organization's deemed status for any of the following reasons: ( 1 ) CMS determines, on the basis of its own investigation, that the MA organization does not meet the Medicare requirements for which deemed status was granted.
( 2 ) CMS withdraws its approval of the accreditation organization that accredited the MA organization.
( 3 ) The MA organization fails to meet the requirements of paragraph (d) of this section.
( f ) *Authority.* Nothing in this subpart limits CMS' authority under subparts K and O of this part, including but not limited to, the ability to impose intermediate sanctions, civil money penalties, and terminate a contract with an MA organization.
[63 FR 35082, June 26, 1998, as amended at 65 FR 40323, June 29, 2000; 65 FR 59749, Oct. 6, 2000; 70 FR 4724, Jan. 28, 2005; 75 FR 19806, Apr. 15, 2010; 76 FR 21564, Apr. 15, 2011; 84 FR 15829, Apr. 16, 2019]